NVNO ▲ +0.1% - enVVeno Medical Corporation
$NVNO - enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
30-OCT-2026 08:30 AM ET
Share this post
More filings for $NVNO
NVNO ▼ -0.4% - enVVeno Medical CorporationOct 2, 2026NVNO ▼ -0.9% - enVVeno Medical CorporationSep 16, 2026NVNO - enVVeno Medical Corporation - SEC Filing Update (15-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 15, 2026NVNO - enVVeno Medical Corporation - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $NVNO filing history →💬 Comments
Loading comments…
Leave a comment